{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T20:46:16Z","timestamp":1790109976624,"version":"4.0.1"},"reference-count":38,"publisher":"The Endocrine Society","issue":"12","license":[{"start":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T00:00:00Z","timestamp":1730246400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100006668","name":"Fondo para la Investigaci\u00f3n Cient\u00edfica y Tecnol\u00f3gica","doi-asserted-by":"publisher","award":["PICT 2019 N0223"],"award-info":[{"award-number":["PICT 2019 N0223"]}],"id":[{"id":"10.13039\/501100006668","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006668","name":"Fondo para la Investigaci\u00f3n Cient\u00edfica y Tecnol\u00f3gica","doi-asserted-by":"publisher","award":["PICT 2021 N0110"],"award-info":[{"award-number":["PICT 2021 N0110"]}],"id":[{"id":"10.13039\/501100006668","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Ministerio de Ciencia, Innovaci\u00f3n y Universidades","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["PID2020-118511RB-I00"],"award-info":[{"award-number":["PID2020-118511RB-I00"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["2021 SGR 00698"],"award-info":[{"award-number":["2021 SGR 00698"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["PRE2018-084480"],"award-info":[{"award-number":["PRE2018-084480"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015439","name":"Centres de Recerca de Catalunya","doi-asserted-by":"publisher","award":["MDM-2017-0729"],"award-info":[{"award-number":["MDM-2017-0729"]}],"id":[{"id":"10.13039\/100015439","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001645","name":"Boehringer Ingelheim Fonds","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001645","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,10,30]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Prolactinomas, the most common pituitary-secreting adenomas, can be effectively treated with dopamine D2 receptor (D2R) agonists. However, a subset of them (\u223c20%) are resistant to dopamine-based therapies and require extirpation. The molecular mechanisms underlying their escape from dopaminergic regulation are not fully elucidated and may include alterations in D2R signaling. D2R can heteromerize with other G protein-coupled receptors, resulting in modulation of dopaminergic signaling. Because the bradykinin receptor type 2 (B2R) is overexpressed in prolactinomas, we interrogated whether this dopaminergic dysregulation observed in some prolactinomas may depend on a physical and functional interaction between D2R and B2R. The formation of B2R-D2R complexes in cultured cells transiently expressing both receptors was validated using NanoBiT technology. Interestingly, although D2R stimulation did not alter B2R-induced intracellular calcium mobilization, B2R stimulation abolished D2R signaling through modulation of cAMP. The existence of B2R-D2R complexes in pituitary adenomas biopsies was evaluated using an ALPHALisa approach. Importantly, B2R-D2R complexes were detected in human prolactinomas and nonfunctioning pituitary adenomas, but not in mixed (prolactin + growth hormone)-secreting adenomas. These results suggest that overexpression of B2R in resistant prolactinomas may promote the formation of B2R-D2R complexes, with B2R precluding D2R signaling, thus generating resistance to D2R agonists.<\/jats:p>","DOI":"10.1210\/endocr\/bqae144","type":"journal-article","created":{"date-parts":[[2024,11,2]],"date-time":"2024-11-02T11:29:56Z","timestamp":1730546996000},"source":"Crossref","is-referenced-by-count":4,"title":["B2R-D2R Interaction in Prolactinomas and Nonfunctional Adenomas: Impact on Dopamine Resistance"],"prefix":"10.1210","volume":"165","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6802-7195","authenticated-orcid":false,"given":"Alejandra","family":"Abeledo-Machado","sequence":"first","affiliation":[{"name":"Laboratorio de Fisiopatolog\u00eda Hormonal, IBYME-CONICET , C1428ADN Buenos Aires ,","place":["Argentina"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4230-7089","authenticated-orcid":false,"given":"Josep","family":"Argerich","sequence":"additional","affiliation":[{"name":"Department of Pathology and Experimental Therapeutics, Pharmacology Unit, School of Medicine and Health Sciences, Institute of Neurosciences, University of Barcelona , 08907 Barcelona ,","place":["Spain"]},{"name":"Neuropharmacology & Pain Group, Neuroscience Program, Bellvitge Institute for Biomedical Research , 08907 Barcelona ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0503-5897","authenticated-orcid":false,"given":"Agust\u00edn","family":"Yaneff","sequence":"additional","affiliation":[{"name":"Facultad de Farmacia y Bioqu\u00edmica, Instituto de Investigaciones Farmacol\u00f3gicas (ININFA-UBA-CONICET), Universidad de Buenos Aires , C1113AAD Buenos Aires ,","place":["Argentina"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2852-6667","authenticated-orcid":false,"given":"Noemi","family":"Vidal","sequence":"additional","affiliation":[{"name":"Neurohatology, Servei d\u00b4Anatomia Patol\u00f2gica, Hospital Universitari de Bellvitge , 08907 Barcelona ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Garc\u00eda-Roca","sequence":"additional","affiliation":[{"name":"Neurohatology, Servei d\u00b4Anatomia Patol\u00f2gica, Hospital Universitari de Bellvitge , 08907 Barcelona ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-1582-2781","authenticated-orcid":false,"given":"Dana","family":"Bornancini","sequence":"additional","affiliation":[{"name":"Laboratorio de Fisiopatolog\u00eda Hormonal, IBYME-CONICET , C1428ADN Buenos Aires ,","place":["Argentina"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1134-4100","authenticated-orcid":false,"given":"Milagros","family":"Pe\u00f1a-Zanoni","sequence":"additional","affiliation":[{"name":"Laboratorio de Fisiopatolog\u00eda Hormonal, IBYME-CONICET , C1428ADN Buenos Aires ,","place":["Argentina"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8189-0388","authenticated-orcid":false,"given":"Mariela M","family":"Gironacci","sequence":"additional","affiliation":[{"name":"Facultad de Farmacia y Bioqu\u00edmica, Departamento de Qu\u00edmica Biol\u00f3gica and IQUIFIB (UBA-CONICET), Universidad de Buenos Aires , C1113AAD Buenos Aires ,","place":["Argentina"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8300-284X","authenticated-orcid":false,"given":"Carina","family":"Shayo","sequence":"additional","affiliation":[{"name":"Laboratorio de Patolog\u00eda y Farmacolog\u00eda Molecular, IBYME-CONICET , C1428ADN Buenos Aires ,","place":["Argentina"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0832-3739","authenticated-orcid":false,"given":"Francisco","family":"Ciruela","sequence":"additional","affiliation":[{"name":"Department of Pathology and Experimental Therapeutics, Pharmacology Unit, School of Medicine and Health Sciences, Institute of Neurosciences, University of Barcelona , 08907 Barcelona ,","place":["Spain"]},{"name":"Neuropharmacology & Pain Group, Neuroscience Program, Bellvitge Institute for Biomedical Research , 08907 Barcelona ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7373-6893","authenticated-orcid":false,"given":"Graciela","family":"D\u00edaz-Torga","sequence":"additional","affiliation":[{"name":"Laboratorio de Fisiopatolog\u00eda Hormonal, IBYME-CONICET , C1428ADN Buenos Aires ,","place":["Argentina"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2024,11,2]]},"reference":[{"issue":"1","key":"2024112608410617400_bqae144-B1","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1159\/000497746","article-title":"Epidemiology and management challenges in prolactinomas","volume":"109","author":"Vroonen","year":"2019","journal-title":"Neuroendocrinology"},{"issue":"1","key":"2024112608410617400_bqae144-B2","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1159\/000495775","article-title":"Management of dopamine agonist-resistant prolactinoma","volume":"109","author":"Maiter","year":"2019","journal-title":"Neuroendocrinology"},{"issue":"1","key":"2024112608410617400_bqae144-B3","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s11102-019-00987-3","article-title":"Dopamine agonist resistant prolactinomas: any alternative medical treatment?","volume":"23","author":"Souteiro","year":"2020","journal-title":"Pituitary"},{"issue":"1","key":"2024112608410617400_bqae144-B4","doi-asserted-by":"crossref","first-page":"R59","DOI":"10.1530\/JME-16-0049","article-title":"Oligomerization of GPCRs involved in endocrine regulation","volume":"57","author":"Kleinau","year":"2016","journal-title":"J Mol Endocrinol"},{"issue":"2","key":"2024112608410617400_bqae144-B5","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1124\/pr.113.008052","article-title":"G protein-coupled receptor oligomerization revisited: functional and pharmacological perspectives","volume":"66","author":"Ferr\u00e9","year":"2014","journal-title":"Pharmacol Rev"},{"issue":"4","key":"2024112608410617400_bqae144-B6","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/35067575","article-title":"Oligomerization of G-protein-coupled transmitter receptors","volume":"2","author":"Bouvier","year":"2001","journal-title":"Nat Rev Neurosci"},{"issue":"5","key":"2024112608410617400_bqae144-B7","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.parkreldis.2004.02.014","article-title":"Adenosine A2A-dopamine D2 receptor-receptor heteromers. Targets for neuro-psychiatric disorders","volume":"10","author":"Ferr\u00e9","year":"2004","journal-title":"Parkinsonism Relat Disord"},{"issue":"2","key":"2024112608410617400_bqae144-B8","doi-asserted-by":"crossref","first-page":"241","DOI":"10.4103\/1673-5374.226388","article-title":"Adenosine A2A-dopamine D2 receptor heteromers operate striatal function: impact on Parkinson\u2019s disease pharmacotherapeutics","volume":"13","author":"Fernandez-Duenas","year":"2018","journal-title":"Neural Regen Res"},{"issue":"10","key":"2024112608410617400_bqae144-B9","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1016\/j.bbamcr.2017.07.012","article-title":"Bradykinin B2 and dopamine D2 receptors form a functional dimer","volume":"1864","author":"Niewiarowska-Sendo","year":"2017","journal-title":"Biochim Biophys Acta\u2014Mol Cell Res"},{"issue":"11","key":"2024112608410617400_bqae144-B10","doi-asserted-by":"crossref","first-page":"e0206443","DOI":"10.1371\/journal.pone.0206443","article-title":"Influence of bradykinin B2 receptor and dopamine D2 receptor on the oxidative stress, inflammatory response, and apoptotic process in human endothelial cells","volume":"13","author":"Niewiarowska-Sendo","year":"2018","journal-title":"PLoS One"},{"issue":"4","key":"2024112608410617400_bqae144-B11","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1677\/ERC-08-0003","article-title":"Protein western array analysis in human pituitary tumours: insights and limitations","volume":"15","author":"Ribeiro-Oliveira","year":"2008","journal-title":"Endocr Relat Cancer"},{"key":"2024112608410617400_bqae144-B12","unstructured":"Supplementary information: DOI:10.5281\/zenodo.13913154; B2R-D2R interaction in prolactinomas and non-functional adenomas: impact on dopamine resistance. doi:10.5281\/zenodo.13913154"},{"key":"2024112608410617400_bqae144-B13","doi-asserted-by":"crossref","first-page":"194","DOI":"10.3389\/fphar.2020.00194","article-title":"Striatal dopamine D2-muscarinic acetylcholine M1 receptor\u2014receptor interaction in a model of movement disorders","volume":"11","author":"Crans","year":"2020","journal-title":"Front Pharmacol"},{"key":"2024112608410617400_bqae144-B14","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1471-2164-12-14","article-title":"Expression of G protein-coupled receptors and related proteins in HEK293, AtT20, BV2, and N18 cell lines as revealed by microarray analysis","volume":"12","author":"Atwood","year":"2011","journal-title":"BMC Genomics"},{"issue":"14","key":"2024112608410617400_bqae144-B15","doi-asserted-by":"crossref","first-page":"3600","DOI":"10.3390\/ijms20143600","article-title":"Revealing adenosine a2a-dopamine d2 receptor heteromers in Parkinson\u2019s disease post-mortem brain through a new alphascreen-based assay","volume":"20","author":"Fern\u00e1ndez-Due\u00f1as","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"3","key":"2024112608410617400_bqae144-B16","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/s41386-020-00872-9","article-title":"Decreased striatal adenosine A2A-dopamine D2 receptor heteromerization in schizophrenia","volume":"46","author":"Valle-Le\u00f3n","year":"2021","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"2024112608410617400_bqae144-B17","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1210\/jc.2010-1692","article-title":"Diagnosis and treatment of hyperprolactinemia: an endocrine society clinical practice guideline","volume":"96","author":"Melmed","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"2024112608410617400_bqae144-B18","doi-asserted-by":"crossref","first-page":"243","DOI":"10.3389\/fphar.2018.00243","article-title":"Essential control of the function of the striatopallidal neuron by pre-coupled complexes of adenosine A2A-dopamine D2 receptor heterotetramers and adenylyl cyclase","volume":"9","author":"Ferr\u00e9","year":"2018","journal-title":"Front Pharmacol"},{"issue":"2","key":"2024112608410617400_bqae144-B19","doi-asserted-by":"crossref","first-page":"222","DOI":"10.2174\/1570159X15666170518151127","article-title":"Dopamine D2 receptors dimers: how can we pharmacologically target them?","volume":"16","author":"Carli","year":"2018","journal-title":"Curr Neuropharmacol"},{"issue":"12","key":"2024112608410617400_bqae144-B20","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1111\/j.1742-4658.2005.04729.x","article-title":"The impact of G-protein-coupled receptor hetero-oligomerization on function and pharmacology","volume":"272","author":"Maggio","year":"2005","journal-title":"FEBS J"},{"issue":"7","key":"2024112608410617400_bqae144-B21","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1515\/revneuro-2017-0087","article-title":"G protein-coupled receptor-receptor interactions give integrative dynamics to intercellular communication","volume":"29","author":"Guidolin","year":"2018","journal-title":"Rev Neurosci"},{"key":"2024112608410617400_bqae144-B22","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/B978-0-444-64125-0.00011-6","article-title":"Structure and function of serotonin GPCR heteromers","volume":"31","author":"Shah","year":"2020","journal-title":"Handb Behav Neurosci"},{"issue":"5","key":"2024112608410617400_bqae144-B23","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1161\/HYPERTENSIONAHA.120.16614","article-title":"Interaction between the angiotensin-(1-7) Mas receptor and the dopamine D2 receptor: implications in inflammation","volume":"77","author":"Rukavina Mikusic","year":"2021","journal-title":"Hypertension"},{"issue":"5","key":"2024112608410617400_bqae144-B24","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.neuropharm.2007.12.011","article-title":"Antagonistic cannabinoid CB1\/dopamine D2 receptor interactions in striatal CB1\/D2 heteromers. A combined neurochemical and behavioral analysis","volume":"54","author":"Marcellino","year":"2008","journal-title":"Neuropharmacology"},{"key":"2024112608410617400_bqae144-B25","doi-asserted-by":"crossref","first-page":"114327","DOI":"10.1016\/j.biopha.2023.114327","article-title":"Unique effect of clozapine on adenosine A2A-dopamine D2 receptor heteromerization","volume":"160","author":"Valle-Le\u00f3n","year":"2023","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"2024112608410617400_bqae144-B26","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1677\/ERC-07-0271","article-title":"Efficacy of a dopamine-somatostatin chimeric molecule, BIM-23A760, in the control of cell growth from primary cultures of human non-functioning pituitary adenomas: a multi-center study","volume":"15","author":"Florio","year":"2008","journal-title":"Endocr Relat Cancer"},{"issue":"2","key":"2024112608410617400_bqae144-B27","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1021\/acschembio.5b00753","article-title":"NanoLuc complementation reporter optimized for accurate measurement of protein interactions in cells","volume":"11","author":"Dixon","year":"2016","journal-title":"ACS Chem Biol"},{"issue":"9","key":"2024112608410617400_bqae144-B28","first-page":"bqac108","article-title":"Sex-specific regulation of prolactin secretion by pituitary bradykinin receptors","volume":"163","author":"Abeledo-Machado","year":"2022","journal-title":"Endocrinol (United States)"},{"issue":"suppl 1","key":"2024112608410617400_bqae144-B29","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1530\/eje.1.02348","article-title":"Combined therapy of somatostatin analogues and dopamine agonists in the treatment of pituitary tumours","volume":"156","author":"Colao","year":"2007","journal-title":"Eur J Endocrinol"},{"issue":"5463","key":"2024112608410617400_bqae144-B30","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1126\/science.288.5463.154","article-title":"Receptors for dopamine and somatostatin: formation of hetero-oligomers with enhanced functional activity","volume":"288","author":"Rocheville","year":"2000","journal-title":"Science"},{"issue":"5","key":"2024112608410617400_bqae144-B31","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1530\/EJE-07-0806","article-title":"Somatostatinergic ligands in dopamine-sensitive and -resistant prolactinomas","volume":"158","author":"Fusco","year":"2008","journal-title":"Eur J Endocrinol"},{"issue":"12","key":"2024112608410617400_bqae144-B32","doi-asserted-by":"crossref","first-page":"6107","DOI":"10.1210\/en.2007-0378","article-title":"Regulation of growth hormone and prolactin gene expression and secretion by chimeric somatostatin-dopamine molecules","volume":"148","author":"Gruszka","year":"2007","journal-title":"Endocrinology"},{"key":"2024112608410617400_bqae144-B33","doi-asserted-by":"crossref","first-page":"1179551420932921","DOI":"10.1177\/1179551420932921","article-title":"Contemporary management of clinically non-functioning pituitary adenomas: a clinical review","volume":"13","author":"AlMalki","year":"2020","journal-title":"Clin Med Insights Endocrinol Diabetes"},{"issue":"5","key":"2024112608410617400_bqae144-B34","doi-asserted-by":"crossref","first-page":"494","DOI":"10.3390\/biomedicines9050494","article-title":"Pituitary adenomas: from diagnosis to therapeutics","volume":"9","author":"Banskota","year":"2021","journal-title":"Biomedicines"},{"issue":"2","key":"2024112608410617400_bqae144-B35","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/s11102-018-0874-6","article-title":"Pathogenesis of non-functioning pituitary adenomas","volume":"21","author":"Zatelli","year":"2018","journal-title":"Pituitary"},{"issue":"15","key":"2024112608410617400_bqae144-B36","first-page":"833","article-title":"Pituitary adenomas and non-functioning pituitary adenomas","volume":"13","author":"Araujo-Castro","year":"2020","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"2024112608410617400_bqae144-B37","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/cen.12684","article-title":"Dopamine receptor subtype 2 expression profile in nonfunctioning pituitary adenomas and in vivo response to cabergoline therapy","volume":"82","author":"Vieira Neto","year":"2015","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"2024112608410617400_bqae144-B38","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s11102-023-01365-w","article-title":"Cabergoline treatment for surgery-na\u00efve non-functioning pituitary macroadenomas","volume":"27","author":"Ayalon-Dangur","year":"2024","journal-title":"Pituitary"}],"container-title":["Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/endo\/advance-article-pdf\/doi\/10.1210\/endocr\/bqae144\/60330951\/bqae144.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/endo\/article-pdf\/165\/12\/bqae144\/60812983\/bqae144.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/endo\/article-pdf\/165\/12\/bqae144\/60812983\/bqae144.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T08:42:58Z","timestamp":1732610578000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/endo\/article\/doi\/10.1210\/endocr\/bqae144\/7866755"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,30]]},"references-count":38,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,10,30]]}},"URL":"https:\/\/doi.org\/10.1210\/endocr\/bqae144","relation":{},"ISSN":["1945-7170"],"issn-type":[{"value":"1945-7170","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,12]]},"published":{"date-parts":[[2024,10,30]]},"article-number":"bqae144"}}